- Home
- HRMY vs AMBP Comparison
HRMY vs AMBP Comparison
Compare HRMY & AMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- AMBP
- Stock Information
- Founded
- HRMY 2017
- AMBP 2021
- Country
- HRMY United States
- AMBP Luxembourg
- Employees
- HRMY N/A
- AMBP N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- AMBP Containers/Packaging
- Sector
- HRMY Health Care
- AMBP Industrials
- Exchange
- HRMY Nasdaq
- AMBP Nasdaq
- Market Cap
- HRMY 1.6B
- AMBP 1.9B
- IPO Year
- HRMY 2020
- AMBP N/A
- Fundamental
- Price
- HRMY $34.09
- AMBP $3.62
- Analyst Decision
- HRMY Strong Buy
- AMBP Buy
- Analyst Count
- HRMY 8
- AMBP 4
- Target Price
- HRMY $52.88
- AMBP $3.30
- AVG Volume (30 Days)
- HRMY 729.2K
- AMBP 2.3M
- Earning Date
- HRMY 05-06-2025
- AMBP 04-24-2025
- Dividend Yield
- HRMY N/A
- AMBP 11.06%
- EPS Growth
- HRMY 13.13
- AMBP N/A
- EPS
- HRMY 2.62
- AMBP N/A
- Revenue
- HRMY $744,852,000.00
- AMBP $5,035,000,000.00
- Revenue This Year
- HRMY $20.06
- AMBP $4.65
- Revenue Next Year
- HRMY $18.40
- AMBP $2.39
- P/E Ratio
- HRMY $12.76
- AMBP N/A
- Revenue Growth
- HRMY 20.62
- AMBP 4.42
- 52 Week Low
- HRMY $26.47
- AMBP $2.50
- 52 Week High
- HRMY $41.61
- AMBP $4.26
- Technical
- Relative Strength Index (RSI)
- HRMY 69.87
- AMBP 65.25
- Support Level
- HRMY $29.82
- AMBP $3.47
- Resistance Level
- HRMY $30.61
- AMBP $3.77
- Average True Range (ATR)
- HRMY 1.15
- AMBP 0.15
- MACD
- HRMY 0.71
- AMBP 0.02
- Stochastic Oscillator
- HRMY 98.91
- AMBP 82.98
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.